Skip to main content

Table 3 Comparison between N-glycan markers and laboratory parameters in IgD MM patients

From: N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma

Correlations NGA2F NG1(6)A2F NG1(3)A2F NA2 NA3F2 NA4
Hb r 0.242 0.531 0.642 0.233 −0.323 −0.241
(n = 20) P 0.304 0.016a 0.002a 0.322 0.164 0.305
TP r −0.076 −0.085 −0.320 −0.604 −0.094 −0.520
(n = 20) P 0.749 0.720 0.170 0.005a 0.695 0.019+
ALB r −0.298 −0.096 −0.033 −0.041 −0.503 −0.418
(n = 20) P 0.203 0.688 0.889 0.863 0.024a 0.067
SLC ratio r −0.456 −0.531 −0.659 −0.353 −0.220 −0.176
(n = 15) P 0.088 0.042a 0.007a 0.197 0.431 0.530
ULC ratio r −0.591 −0.549 −0.587 −0.411 −0.393 −0.166
(n = 16) P 0.040a 0.015+ 0.017a 0.114 0.132 0.583
  1. Abbreviations: Hb haemoglobulin, TP total protein, ALB albumin, SLC serum light chain, ULC urine light chain
  2. Using κ/λ ratio for IgD κ MM patients and λ/κ ratio for IgD λ MM patients
  3. arepresents N-glycan biomarkers with a significant correlation with corresponding laboratory indexes